ARCHIVES

DCE Board Approves Epidemiology Contract Recompetitions

This article is from The Cancer Letter archive.

Vol. 21 No. 11 | March 17, 1995

Download PDF Visit The Full Archive

Related Articles

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

May 4, 2001

Prevention, Centers To Gain, some $$ In President’s Budget

February 8, 1991

GAO: FDA Data On Drug Shortages Inadequate

February 21, 2014

Organ Site Review Committee Recommends Continuing Program Despite Some Weak Areas, Suggests Changes

February 5, 1982

New CIS Regions Draw Support, Some Objections

July 5, 1991

Congress Provides 7% Increase For NIH, 6.6% for NCI, In FY98 Appropriation

November 14, 1997